| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.582 | 19.668 | 18.995 | 17.772 | 15.080 | 8.979 | 12.402 | 14.105 | 13.483 | 16.094 |
| Total Income - EUR | 21.582 | 19.668 | 18.995 | 17.772 | 15.080 | 8.979 | 12.402 | 14.105 | 13.483 | 16.094 |
| Total Expenses - EUR | 23.848 | 21.947 | 19.284 | 16.999 | 16.860 | 11.014 | 13.546 | 13.601 | 12.683 | 14.002 |
| Gross Profit/Loss - EUR | -2.267 | -2.280 | -289 | 772 | -1.780 | -2.036 | -1.144 | 504 | 800 | 2.092 |
| Net Profit/Loss - EUR | -2.914 | -2.774 | -859 | 239 | -2.233 | -2.295 | -1.144 | 316 | 672 | 1.755 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Viriomeda S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.321 | 6.750 | 8.409 | 9.216 | 6.863 | 5.144 | 3.883 | 4.959 | 5.098 | 7.782 |
| Inventories | 6.268 | 6.002 | 8.124 | 8.383 | 6.069 | 4.535 | 2.508 | 3.631 | 3.448 | 3.381 |
| Receivables | 0 | 0 | 0 | 412 | 0 | 56 | 0 | 2 | 0 | 0 |
| Cash | 54 | 748 | 285 | 422 | 794 | 553 | 1.375 | 1.326 | 1.650 | 4.400 |
| Shareholders Funds | -51.482 | -53.731 | -53.229 | -52.013 | -53.238 | -54.524 | -54.459 | -54.313 | -53.477 | -51.423 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 57.803 | 60.481 | 61.638 | 61.229 | 60.101 | 59.669 | 58.342 | 59.272 | 58.575 | 59.205 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Viriomeda S.r.l.